Capital Research Global Investors’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $18.2M | Sell |
|
|||||
|
2024
Q4 | $31.8M | Buy |
|
|||||
|
2024
Q3 | $23.7M | Sell |
|
|||||
|
2024
Q2 | $70.8M | Sell |
|
|||||
|
2024
Q1 | $210M | Buy |
|
|||||
|
2023
Q4 | $187M | Buy |
|
|||||
|
2023
Q3 | $117M | Sell |
|
|||||
|
2023
Q2 | $134M | Sell |
|
|||||
|
2023
Q1 | $220M | Hold |
|
|||||
|
2022
Q4 | $214M | Buy |
|
|||||
|
2022
Q3 | $132M | Sell |
|
|||||
|
2022
Q2 | $209M | Sell |
|
|||||
|
2022
Q1 | $438M | Sell |
|
|||||
|
2021
Q4 | $551M | Sell |
|
|||||
|
2021
Q3 | $565M | Sell |
|
|||||
|
2021
Q2 | $563M | Buy |
|
|||||
|
2021
Q1 | $569M | Sell |
|
|||||
|
2020
Q4 | $535M | Sell |
|
|||||
|
2020
Q3 | $423M | Sell |
|
|||||
|
2020
Q2 | $438M | Buy |
|
|||||
|
2020
Q1 | $409M | Buy |
|
|||||
|
2019
Q4 | $532M | Buy |
|
|||||
|
2019
Q3 | $544M | Buy |
|
|||||
|
2019
Q2 | $506M | Buy |
|
|||||
|
2019
Q1 | $501M | Sell |
|
|||||
|
2018
Q4 | $435M | Sell |
|
|||||
|
2018
Q3 | $671M | Buy |
|
|||||
|
2018
Q2 | $629M | Buy |
|
|||||
|
2018
Q1 | $532M | Buy |
|
|||||
|
2017
Q4 | $460M | Buy |
|
|||||
|
2017
Q3 | $306M | Buy |
|
|||||
|
2017
Q2 | $212M | Buy |
|
|||||
|
2017
Q1 | $50.2M | Sell |
|
|||||
|
2016
Q4 | $79.9M | Buy |
|
|||||
|
2016
Q3 | $75.5M | Buy |
|
|||||
|
2016
Q2 | $40.8M | Buy |
|